Orford Keith 4
4 · Calithera Biosciences, Inc. · Filed Jan 22, 2020
Insider Transaction Report
Form 4
Orford Keith
SR. VP, CLINICAL DEVELOPMENT
Transactions
- Award
Stock Option (Right to Buy)
2020-01-17+140,000→ 140,000 totalExercise: $7.41Exp: 2030-01-17→ Common Stock (140,000 underlying)
Footnotes (1)
- [F1]One-fourth (1/4th) of the Option vests one year after January 17, 2020; the balance of the Option vests in a series of thirty-six (36) successive equal monthly installments thereafter. The Option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company.